Results 181 to 190 of about 556,517 (293)

SNUPN‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective SNUPN‐related muscular dystrophy or LGMDR29 is a new entity that covers from a congenital or childhood onset pure muscular dystrophy to more complex phenotypes combining neurodevelopmental features, cataracts, or spinocerebellar ataxia. So far, 12 different variants have been described.
Nuria Muelas, Pablo Iruzubieta, Alberto Damborenea, Laura Pérez‐Fernández, Inmaculada Azorín, Juan Carlos Jiménez García, Ana Töpf, Pilar Martí, Lorena Fores‐Toribio, María Manterola, Rosana Blanco‐Mañez, Oihane Pikatza‐Menoio, Sonia Alonso‐Martín, Volker Straub, Aitziber L. Cortajarena, Adolfo López de Munain, David De Sancho, Lorea Blázquez, Juan J. Vilchez   +18 more
wiley   +1 more source

Oxidation-reduction imaging of myoglobin reveals two-phase oxidation in the reperfused myocardium. [PDF]

Basic Res Cardiol
Badawi S, Leboullenger C, Chourrout M, Gouriou Y, Paccalet A, Pillot B, Augeul L, Bolbos R, Bongiovani A, Mewton N, Bochaton T, Ovize M, Tardivel M, Kurdi M, Canet-Soulas E, Da Silva CC, Bidaux G.   +16 more
europepmc   +1 more source

Impact of APOE ε4 Genotype Load on Cognitive Function and Lipid Metabolism in Patients With Cerebral Small Vessel Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Apolipoprotein ε4 (APOE ε4) is a potent genetic risk factor for Alzheimer's disease (AD). However, its role in cerebral small vessel disease (CSVD) remains unclear. Given the clinical and pathological similarities between CSVD and AD, this study aimed to investigate the associations of APOE ε4 gene dosage with cognitive function and
Tingru Jin, Haocheng Yang, Feng Liu, Sihao Lin, Junru Hu, Jian Wang, Yulan Gou   +6 more
wiley   +1 more source

In Situ STM Study of Roughening of Au(111) Single-Crystal Electrode in Sulfuric Acid Solution during Oxidation-Reduction Cycles. [PDF]

J Phys Chem C Nanomater Interfaces
Behjati S, Koper MTM.
europepmc   +1 more source

From photosynthesis to photocatalysis: Dual catalytic oxidation/reduction in one system. [PDF]

Proc Natl Acad Sci U S A, 2020
Chen LX.
europepmc   +1 more source

Monitoring Site-Specific Fermentation Outcomes via Oxidation Reduction Potential and UV-Vis Spectroscopy to Characterize "Hidden" Parameters of Pinot Noir Wine Fermentations. [PDF]

Molecules, 2021
Walker GA, Nelson J, Halligan T, Lima MMM, Knoesen A, Runnebaum RC.   +5 more
europepmc   +1 more source

Catalytic Behavior during Hydrocarbon Combustion and Selective Catalytic Reduction of Nitric Oxide

, 1999
Tetsuya Nanba
openalex   +2 more sources

Plasma Proteomic Signatures for Alzheimer's Disease: Comparable Accuracy to ATN Biomarkers and Cross‐Platform Validation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu, Oliver Robinson, Christina M. Lill, Anna Matton, Raquel Puerta, Pilar Sanz, Merce Boada, Agustín Ruiz, Lefkos Middleton, for the Alzheimer's Disease Neuroimaging Initiative   +9 more
wiley   +1 more source

Diagnostic value of oxidation-reduction potential for male infertility: a systematic review and meta-analysis. [PDF]

Transl Androl Urol
Tan Y, Yuan Y, Yang X, Wang Y, Liu L.
europepmc   +1 more source

Analysis of atmospheric oxidation capacity changes in Europe resulting from emission reductions

Daeun Jung
openalex   +1 more source